278 related articles for article (PubMed ID: 31353194)
1. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data.
Islam RM; Bell RJ; Green S; Page MJ; Davis SR
Lancet Diabetes Endocrinol; 2019 Oct; 7(10):754-766. PubMed ID: 31353194
[TBL] [Abstract][Full Text] [Related]
2. Testosterone therapy and other treatment modalities for female sexual dysfunction.
Ingram CF; Payne KS; Messore M; Scovell JM
Curr Opin Urol; 2020 May; 30(3):309-316. PubMed ID: 32205812
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954
[TBL] [Abstract][Full Text] [Related]
5. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Kingsberg SA; Simon JA; Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
[TBL] [Abstract][Full Text] [Related]
6. Testosterone for low libido in postmenopausal women not taking estrogen.
Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
[TBL] [Abstract][Full Text] [Related]
7. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
Kingsberg S
J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
[TBL] [Abstract][Full Text] [Related]
8. Androgens and Female Sexual Function and Dysfunction--Findings From the Fourth International Consultation of Sexual Medicine.
Davis SR; Worsley R; Miller KK; Parish SJ; Santoro N
J Sex Med; 2016 Feb; 13(2):168-78. PubMed ID: 26953831
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
11. [The Role of Testosterone in The Improvement of Sexual Desire in Postmenopausal Women: An Evidence-Based Clinical Review].
Gouveia M; Sanches R; Andrade S; Carmona S; Ferreira C
Acta Med Port; 2018 Nov; 31(11):680-690. PubMed ID: 30521462
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
13. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
14. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
Basaria S; Dobs AS
J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women.
Jayasena CN; Alkaabi FM; Liebers CS; Handley T; Franks S; Dhillo WS
Clin Endocrinol (Oxf); 2019 Mar; 90(3):391-414. PubMed ID: 30488972
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
[TBL] [Abstract][Full Text] [Related]
17. Androgen therapy in women, beyond libido.
Davis SR
Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
20. Effects of testosterone therapy for women: a systematic review and meta-analysis protocol.
Islam RM; Bell RJ; Green S; Davis SR
Syst Rev; 2019 Jan; 8(1):19. PubMed ID: 30635029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
